Pradžia › Ūmi limfoblastinė leukemija
Ūmi limfoblastinė leukemija klinikiniai tyrimai JAV ieško dalyvių
134 tyrimai dėl Ūmi limfoblastinė leukemija ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Houston, TX28 tyrimai
- New York City, NY24 tyrimai
- Baldwin Park, CA21 tyrimas
- Seattle, WA21 tyrimas
- Chicago, IL19 tyrimai
- Atlanta, GA19 tyrimai
- Philadelphia, PA16 tyrimai
- Memphis, TN16 tyrimai
- Washington, DC16 tyrimai
- Boston, MA15 tyrimai
- Los Angeles, CA14 tyrimai
- Durham, NC13 tyrimai
- Mountain View, CA13 tyrimai
- Cincinnati, OH12 tyrimai
- Minneapolis, MN12 tyrimai
- Columbus, OH11 tyrimai
- Tampa, FL10 tyrimai
- Salt Lake City, UT10 tyrimai
- Baltimore, MD9 tyrimai
- Portland, OR9 tyrimai
- Miami, FL8 tyrimai
- Aurora, CO8 tyrimai
- San Antonio, TX8 tyrimai
- Nashville, TN8 tyrimai
- Edison, NJ8 tyrimai
- Charlotte, NC8 tyrimai
- Cleveland, OH7 tyrimai
- Birmingham, AL7 tyrimai
- Denver, CO7 tyrimai
- Pittsburgh, PA6 tyrimai
- Oklahoma City, OK6 tyrimai
- Milwaukee, WI6 tyrimai
- Detroit, MI6 tyrimai
- Phoenix, AZ6 tyrimai
- San Diego, CA6 tyrimai
- St. Louis, MO6 tyrimai
- Queens, NY6 tyrimai
- San Francisco, CA5 tyrimai
- Clifton, NJ5 tyrimai
- The Bronx, NY5 tyrimai
Pagal valstiją
- Ajova5 tyrimai
- Alabama7 tyrimai
- Arizona6 tyrimai
- Arkansas5 tyrimai
- Džordžija20 tyrimai
- Florida19 tyrimai
- Havajai3 tyrimai
- Ilinoisas20 tyrimai
- Indianas6 tyrimai
- Kalifornija40 tyrimai
- Kanzasas5 tyrimai
- Kentukis4 tyrimai
- Koloradas12 tyrimai
- Kolumbijos apskritis10 tyrimai
- Konektikutas3 tyrimai
- Luiziana6 tyrimai
- Masčusetsas15 tyrimai
- Menas3 tyrimai
- Merilendas16 tyrimai
- Minesota14 tyrimai
- Misisipė3 tyrimai
- Misūris6 tyrimai
- Mičiganas8 tyrimai
- Nebraska4 tyrimai
- Nevada3 tyrimai
- New Jersey11 tyrimai
- New Mexico3 tyrimai
- New York32 tyrimai
- North Carolina21 tyrimas
- Ohio21 tyrimas
- Oklahoma8 tyrimai
- Oregon10 tyrimai
- Pennsylvania21 tyrimas
- Rhode Island3 tyrimai
- South Carolina5 tyrimai
- South Dakota3 tyrimai
- Tennessee22 tyrimai
- Texas30 tyrimai
- Utah10 tyrimai
- Virginia9 tyrimai
- Washington22 tyrimai
- West Virginia4 tyrimai
- Wisconsin9 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Renkami dalyviai1 fazė
Iki 75 metų · Visoms lytims · Atnaujinta 2026-10-02 · NCT01853631A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Renkami dalyviai
Amžius nuo 1 iki 25 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05621291Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Renkami dalyviai1 fazė
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06904066Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Renkami dalyviai1 fazė
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07572136Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 0 iki 38 · Visoms lytims · Atnaujinta 2026-10-01 · NCT06131801CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Renkami dalyviai2 fazė
Amžius nuo 3 iki 65 · Visoms lytims · Atnaujinta 2026-09-30 · NCT07328503CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Renkami dalyviai1/2 fazė
Amžius nuo 3 iki 39 · Visoms lytims · Atnaujinta 2026-09-30 · NCT05442515A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Renkami dalyviai1 fazė
Amžius nuo 12 iki 78 · Visoms lytims · Atnaujinta 2026-09-29 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Renkami dalyviai2 fazė
6 Months · Visoms lytims · Atnaujinta 2026-09-28 · NCT06514794Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06144606Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT06398457Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Renkami dalyviaiStebimasis tyrimas
4 Weeks – 18 Years · Visoms lytims · Atnaujinta 2026-09-24 · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT06308588Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT06819475A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Renkami dalyviai1/2 fazė
30 Days · Visoms lytims · Atnaujinta 2026-09-16 · NCT04065399A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Renkami dalyviai1 fazė
Amžius nuo 0 iki 18 · Visoms lytims · Atnaujinta 2026-09-16 · NCT06173518Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT06904482Cord Blood Transplant in Adults With Blood Cancers
Renkami dalyviai2 fazė
Amžius nuo 21 iki 65 · Visoms lytims · Atnaujinta 2026-09-11 · NCT05884333Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
Renkami dalyviai1/2 fazė
Amžius nuo 16 iki 75 · Visoms lytims · Atnaujinta 2026-09-10 · NCT03104491Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
Renkami dalyviai1 fazė
Amžius nuo 1 iki 25 · Visoms lytims · Atnaujinta 2026-09-01 · NCT06408194First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT07586618Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Iki 50 metų · Visoms lytims · Atnaujinta 2026-09-01 · NCT05322850Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
Renkami dalyviai1 fazė
Iki 21 metų · Visoms lytims · Atnaujinta 2026-08-31 · NCT04881240CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
Renkami dalyviai1 fazė
Iki 21 metų · Visoms lytims · Atnaujinta 2026-08-28 · NCT07257419Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.